2nd ESTRO Forum 2013 area. Different analysis techniques have been proposed to increase the accuracy of radiochromic films dose distribution measurements. The aim of this work is to compare the results obtained whit different analysis techniques in assessing dose distribution for IMRT photon beams pre-treatment verification. Materials and Methods: Gafchromic®EBT3 films have been calibrated irradiating 5x5 cm film pieces with a 6 MV linac photon beam at different dose levels in a range from 10 to 400 cGy at 5cm depth in PMMA phantom and SSD 95 cm. Then 40 IMRT clinical beams have been verified by gafchromic films with the same irradiation setup. Films have been scanned with a Epson 10000XL flatbed scanner 24 hours after irradiation and dose distributions have been assessed using an home-made software. Our software allows to perform analysis in 4 different ways: red channel (R) analysis, red channel analysis with the correction for the scanner non-uniformities (RC), the red/blue channels (RB) analysis and the 3 channel (RGB) analysis using formulas proposed by Mayer (Med. Phys. 2012). The films absolute dose distributions obtained have been compared with the calculated ones by means of 3%(local)/3mm gamma analysis. Results: Gamma analysis pass rates obtained with RGB analysis (98.0±2.7) are higher than pass rates obtained with all the other analysis approaches, while the lowest mean pass rate (88.9±13.3) has been obtained, as is was expected, evaluating the dose distribution using the R analysis. Comparing RB and RC techniques, the last one provide better results (96.5 ± 3.4 vs 94.1 ± 7.2). Moreover standard deviations of mean values are inversely proportional to gamma pass rates meaning that methods giving higher pass rates are also more consistent.
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The Netherlands Cancer Institute -Antoni van Leeuwenhoek Hospital, Radiotherapy, Amsterdam, The Netherlands Purpose/Objective: Verification of the position of MLC leaves is an essential part of routine linac quality assurance. This is particularly true when more advanced treatment techniques such as VMAT/RapidArc and IMRT are used. These treatments are typically built up out of smaller, possibly abutting fields, amplifying the effect of any mispositioning of the leaves. The Elekta Agility MLC (Elekta, Crawley, UK) has 160 leaves, with 0.5 cm effective leaf width in the isocentre. It comes with an automated tool to calibrate the leaf position offsets and motion gains. This is a 'black-box', and direct control over leaf positioning is no longer possible, but independent verification is still essential. The aim of the research presented was twofold: 1. To test the MLCSoftEPID software (PTW, Freiburg, Germany) as a quick tool for routine MLC QA, as an alternative to detector arrays or film. 2. To test the positioning stability of the Elekta Agility MLC. Materials and Methods: An Elekta Synergy linac fitted with an Agility MLC was used. The EPID used was an IviewGT amorphous silicon 1024x1024 pixel EPID, with a 41x41 cm detection area (Perkin-Elmer, Waltham Massachusetts, US). MLCSoftEPID software was used for analysis. This software package requires a standard set of EPID images to be acquired for accurate alignment of the coordinate system of the EPID panel in relation to the linac collimator, followed by a series of strip images from which the leaf positions are then determined, analogous to a picket-fence test. Measurements were compared to our institute's standard SLA-48 (PTW, Freiburg, Germany), a linear array of ionization chambers mounted on a stepper motor. To test whether the measurement of a leaf's position is influenced by the position of neighbouring leaves, images were also made with all odd-numbered leaves intentionally offset by 2 mm compared to even-numbered leaves. In this case, the 50% dose level is no longer directly beneath what would normally be considered the leaf position, due to the nonzero size of the point spread function (see figure) . Positioning accuracy for each leaf was tracked biweekly over a period of multiple months.
Results:
A routine leaf position QA check using MLCSoftEPID can be done within 10 minutes. Consecutive leaf position measurements using the EPID were found to be reproducible within 0.1mm every time, comparable to or better than traditional alternatives, and agree with conventional SLA-48 measurements within 0.3 mm. Over the 3 months during which leaf stability was measured, all individual leaf positions of the Agility deviated by less than 0.2mm. A non-negligible effect caused by a mispositioning of neighbouring leaves on the position of a leaf as measured by EPID was found. The size of this effect is on the order of 25% of the neighbouring leaf's offset.
Conclusions:
The leaf positioning stability of the Elekta Agility is within 0.2mm, over a 3 month period half a year after installation. The MLCSoftEPID software is a useful alternative to current methods of leaf positioning QA used in our institute. In this feasibility study we compare this feature in the commercially available 3DVH option of ArcCheck (SunNuclear) with the EPID based 3D dosimetry approach that was developed by the NKI-AVL in Amsterdam and that is being tested in our hospital. Materials and Methods: For two different clinical VMAT cases (prostate & oesophagus) planned with MONACO (Elekta) we measured the clinical treatment plans on a cylindrical phantom with ArcCheck and a rectangular phantom with EPID dosimetry at a Synergy (Elekta) linac. ArcCheck translates deviations measured by the diodes at the outer boundary of the phantom to deviations in the delivered patient dose.The EPID dosimetry uses a back projection algorithm to convert doses measured at the EPID to 3D doses inside the patient or phantom. To study the sensitivity of both methods, two types of delivery errors have been introduced in the delivered treatment plans. Systematic errors in the leaf position calibration of 0.5, 1, 1.5, and 2mm (open or close) and fixing leaf positions during treatment (of 1 or 2 leaves). We have compared the gamma-statistics (3%/3mm) and the measured and planned DVHs.
PO-0790 DVH measurements for VMAT
Results: In Fig. 1 DVHs of PTV and two OARs are shown for Monaco, 3DVH, and EPID dosimetry for the two cases without introduced errors. The prostate case shows reasonable resemblance for all volumes, although the measured PTV dose spread is larger than planned and doses are somewhat higher for the EPID dosimetry. The latter is probably due to the phantom shape being smaller than the patient, yielding higher doses. This is a disadvantage of direct DVH measurements in phantoms. Likewise, the oesophagus case shows lower EPID dosimetry values. To reduce the effect of shape differences, we show the relative dose difference as a result of the introduced errors (with respect to the original DVHs of Fig. 1) in Table  1 . It is clear that both systems can distinguish larger from smaller errors, but although the mean difference between the relative Dmean changes is small (0.4%), the standard deviation is still considerable (3.6%). Further investigations are required to validate DVH measurements of both systems.
Conclusions: Current dosimetry techniques can measure DVHs of VMAT plans but clinical implementation requires further verification of the results shown by these systems. We are developing more extensive tests for this purpose. 
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MAASTRO Clinic, Radiotherapy, Maastricht, The Netherlands
Purpose/Objective: The aim of radiation theragnostics is to integrate functional and molecular imaging data into radiation treatment planning to generate a heterogeneous dose prescription that takes into account 3D-profiles of a specific biological parameter (e.g. FDG tumour uptake, hypoxia, drug uptake). It is of crucial importance to develop preclinical models to identify the best scenarios to be further tested in clinical trials. Our group is investigating the validity of molecular imaging-based 'radiation dose painting' in a rat rhabdomyo-sarcoma model. The size of biological targeted volumes (BTVs) obtained by PET-based segmentation entails the irradiation of small fields (<2 cm 3 ). The aim of the present study was to test the accuracy of two calculation algorithms for small field doses, both in the case of static beams and arc treatment, such as with Rapid Arc. Materials and Methods: Dose calculations were performed using Eclipse version 10.0 (Varian Medical Systems, Palo Alto) with the anisotropic analytical algorithm (AAA) and the Acuros XB algorithm. The beam models for both algorithms were generated from data collected for a 6 MV beam of a Varian Truebeam linear accelerator with a 120 leaf Millennium MLC using acc13 ion chamber (PTW) and a diamond detector (PTW). We investigated dose accuracy for square fields (between 0.5x0.5 cm 2 and 4x4 cm 2 ) and several rectangular fields (between 0.5x0.8 cm 2 and 2x3 cm 2 ) irradiated with a static beam. Acuros XB and AAA were configured for stereotactic use,and dose calculations were performed with a grid size set at 1 mm. The impact of different focal spot sizes on dose calculations was also assessed. Comparing measurements of output factors(OFs) and percentage depth dose values (PDDs) were performed with Gafchromic EBT2 films (ISP) in water equivalent phantoms. Film dose analysis and comparison with Eclipse output dose distributions were performed using a triple-channel dosimetry method. Results: The dose algorithms predicted OFs within 1% of the values measured by detector and film measurements. However, for fields below 1x1 cm 2 , for which no calibration data can be included in the beam model, the discrepancy with film measurements was highly dependent on the focal spot size. Differences between Eclipse prediction and film measurements were between 3% and 10% for field sizes of 0.8 x 0.8 cm 2 and 0.5x0.5 cm 2 , respectively. Conclusions: Our preliminary results show that for commissioning of MV photon beams for small fields, EBT2 film dosimetry might allow to better quantify accuracy of dose calculations compared to diode and diamond detector dosimetry. We are currently testing accuracy of dose calculations by EBT2 film dosimetry, using appropriate phantoms, also for heterogeneous treatment plans prepared on our preclinical tumour model. Altogether, our work will prove the feasibility and provide the methodology to test radiation 'dose painting' preclinically using state-of-the-art clinical platforms. Purpose/Objective: Patient-specific quality assurance is necessary to evaluate the deliverability and accuracy of advanced radiation therapy deliveries, however the ability of different detector types to flag treatment plans as problematic is poorly understood. Materials and Methods: Five VMAT treatment plans were developed using the Eclipse v 8.8 treatment planning system (Varian Medical Systems, Palo Alto, CA, USA). The treatment plans were then imported into a custom in-house software program that was designed to systematically modify both banks of the MLC leaf positions by ±0.5, ±1 and ±2 mm (Note +=MLC open, -=MLC close). The modified treatment plans were then simulated with errors introduced and then delivered to radiochromic film, EPID and the ArcCheck device (SunNuclear Corporation, Melbourne, FL, USA). The simulated plans for the EPID were modified such that all control points occurred at gantry=0°. The plans were evaluated as simulations in Eclipse and then delivered to the detectors. Analysis was done with gamma analysis (Dd=2%,DTA=2mm) using the un-modified plan as the reference. Results: For the Eclipse simulations, ArcCheck produced the largest average gamma value change for all magnitudes of MLC positional errors. Linear regression of gamma change per mm MLC gap change yielded slopes of 0.31 Δgamma/mm for ArcCheck, 0.26 Δgamma/mm for EPID and 0.22 Δgamma/mm for radiochromic film.Eclipse simulation agreed with experimental measurement within <5% for ArcCheck and EPID but not for film. Conclusions: Sensitivity analysis of three different detectors were analysed for 5 VMAT prostate cases and yielded ArcCheck as the most sensitive detector followed by EPID and then film. Future components to this study will investigate smaller magnitudes of error (i.e ±0.1 and 0.25 mm) and will analyse γ(2%,2mm) pass rates for these detectors to understand each detectors sensitivity for catching MLC open/close positional errors.
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